Possible outcomes of reassortment in vivo between wild type and live attenuated influenza vaccine strains

Vaccine

Volumn 30, Issue 51, 2012, Pages 7395-7399

  Kiseleva, Irina ^a   Dubrovina, Irina ^a   Bazhenova, Ekaterina ^a   Fedorova, Ekaterina ^a   Larionova, Natalie ^a   Rudenko, Larisa ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Live influenza vaccine; Reassortment in vivo; Transmission

Indexed keywords

INFLUENZA VACCINE; PLACEBO;

2009 H1N1 INFLUENZA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GENETIC REASSORTMENT; IN VIVO STUDY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGENY; SKIN BLEEDING; TEMPERATURE; VIRUS DETECTION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; WEIGHT REDUCTION;

ANIMALS; FEMALE; GUINEA PIGS; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; REASSORTANT VIRUSES; RECOMBINATION, GENETIC; TREATMENT OUTCOME; VACCINES, ATTENUATED; VIRULENCE;

EID: 84870239945     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.09.076     Document Type: Article

References (11)

1. Lowen A.C., Mubareka S., Tumpey T.M., Garcia-Sastre A., Palese P. The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci U S A 2006, 103:9988-9992.
2. Parks C.L., Latham T., Cahill A., O'Neill R.E., Passarotti C.J., Buonagurio D.A., et al. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain. Virology 2007, 367:275-287.
3. WHO manual on animal influenza diagnosis and surveillance. Edition of 2002. Available from: [accessed 06.12.11]. http://www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev.pdf.
4. Reed L., Muench H. A simple method of estimating fifty per cent endpoints. Am J Hygiene 1938, 27:493-497.
5. Klimov A.I., Cox N.J. PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines. J Virol Methods 1995, 52:41-49.
6. Zambon M.C., Stockton J.D., Clewley J.P., Fleming D.M. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 2001, 358:1410-1416.
7. Nichol K.L. Live attenuated influenza virus vaccines: new options for the prevention of influenza. Vaccine 2001, 19:4373-4377.
8. Rudenko L.G., Slepushkin A.N., Monto A.S., Kendal A.P., Grigorieva E.P., Burtseva E.P., et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis 1993, 168:881-887.
9. Lin Y.P., Gregory V., Bennett M., Hay A. Recent changes among human influenza viruses. Virus Res 2004, 103:47-52.
10. Shaw M.W., Arden N.H., Maassab H.F. New aspects of influenza viruses. Clin Microbiol Rev 1992, 5:74-92.
11. Matrosovich M., Tuzikov A., Bovin N., Gambaryan A., Klimov A., Castrucci M.R., et al. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol 2000, 74:8502-8512.